This article was originally published in The Gray Sheet
Executive SummaryBoard of directors has extended expiration date of outstanding warrants by one year, to June 19, 1994. Each warrant issued in Staodyn's 1991 financing entitles the holder to purchase one share of common stock at $8.50. The terms of the warrants will remain unchanged, according to an April 2 release announcing the extension. Staodyn had previously said that it might not extend the warrants ("The Gray Sheet" March 22, p. 21).
You may also be interested in...
Senate Finance Committee’s approach to penalize companies for raising WAC list prices is not a ‘price control,’ but a reasonable approach to change the incentives that distort pricing in the supply chain, US HHS Secretary Alex Azar says.
With the pre-GDUFA backlog largely acted upon, the FDA expects ANDA approvals to decrease, but supplement actions to increase in FY 2020 and FY 2021.
February and March inspections deferred unless any are deemed mission critical. China director remains behind as staff evacuate.